Free Trial

Skye Bioscience (SKYE) SEC Filings & 10K Form

Skye Bioscience logo
$3.14 -0.11 (-3.38%)
Closing price 04:00 PM Eastern
Extended Trading
$3.17 +0.03 (+0.96%)
As of 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Skye Bioscience SEC Filings

DateFilerForm TypeView
06/11/2025
4:13 PM
Skye Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2025
4:27 PM
Skye Bioscience (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
Form SCHEDULE 13G/A
03/20/2025
3:03 PM
Skye Bioscience (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/20/2025
3:04 PM
Skye Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2025
5:54 PM
ARSENAULT KAITLYN (Reporting)
Skye Bioscience (Issuer)
Form 4/A
02/26/2025
6:45 PM
Schwab Andrew J. (Reporting)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
4:53 PM
ARSENAULT KAITLYN (Reporting)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
4:27 PM
Skye Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
4:34 PM
Arora Puneet S. (Reporting)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
4:38 PM
Diep Tuan Tu (Reporting)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
4:41 PM
Charych Deborah H. (Reporting)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
4:43 PM
DHILLON PUNIT (Reporting)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
4:45 PM
Skye Bioscience (Issuer)
Smith Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
4:47 PM
Grayson Paul A. (Reporting)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
4:51 PM
Jenkins Annalisa (Reporting)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
5:09 PM
5AM Partners VII, LLC (Filed by)
Skye Bioscience (Subject)
Form SCHEDULE 13D/A
11/20/2024
7:23 AM
Diep Tuan Tu (Reporting)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
8:57 PM
ARSENAULT KAITLYN (Reporting)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
8:14 PM
Grayson Paul A. (Reporting)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
8:20 PM
DHILLON PUNIT (Reporting)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
4:22 PM
Grayson Paul A. (Reporting)
Skye Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/15/2024
4:25 PM
Diep Tuan Tu (Reporting)
Skye Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/15/2024
4:28 PM
DHILLON PUNIT (Reporting)
Skye Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/15/2024
4:31 PM
ARSENAULT KAITLYN (Reporting)
Skye Bioscience (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
9:02 AM
JANUS HENDERSON GROUP PLC (Filed by)
Skye Bioscience (Subject)
Form SC 13G/A
11/14/2024
8:21 AM
Altium Capital Management LP (Filed by)
Skye Bioscience (Subject)
Form SC 13G/A
10/30/2024
7:25 PM
Jenkins Annalisa (Reporting)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
7:25 PM
Charych Deborah H. (Reporting)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
7:28 PM
Skye Bioscience (Issuer)
Smith Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
7:29 PM
Grayson Paul A. (Reporting)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
7:30 PM
Schwab Andrew J. (Reporting)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
7:31 PM
DHILLON PUNIT (Reporting)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
7:32 PM
ARSENAULT KAITLYN (Reporting)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
7:33 PM
Diep Tuan Tu (Reporting)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
4:25 PM
Skye Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
3:59 PM
Skye Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
4:25 PM
Skye Bioscience (Filer)
Form DEF 14A
09/13/2024
5:54 PM
5AM CO-INVESTORS II LP (Reporting)
5AM Partners II, LLC (Reporting)
5AM Partners VII, LLC (Reporting)
5AM Ventures II LP (Reporting)
5AM Ventures VII, L.P. (Reporting)
DIEKMAN JOHN D (Reporting)
PARMAR KUSH (Reporting)
ROCKLAGE SCOTT M (Reporting)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
5:56 PM
Schwab Andrew J. (Reporting)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:18 PM
Skye Bioscience (Filer)
Form PRE 14A
09/04/2024
5:12 PM
Arora Puneet S. (Reporting)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s national nightmare is here (Ad)

Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.

Watch the National Emergency broadcast here
09/04/2024
4:25 PM
Arora Puneet S. (Reporting)
Skye Bioscience (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/27/2024
4:20 PM
DHILLON PUNIT (Reporting)
Skye Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SKYE) was last updated on 8/13/2025 by MarketBeat.com Staff
From Our Partners